Filing Flows › Agape ATP (ATPC) › Q2 2025
Agape ATP (ATPC) Q2 2025 earnings results (second quarter 2025)
10-Q filed Aug 13, 2025
Agape ATP (ATPC) reported revenue of $465K for the second quarter 2025 (Q2 2025), +49% from a year earlier and +61% from the quarter before. Operating margin was -133.5%, net loss $617K (132.6% of revenue).
Agape ATP, Q2 2025: revenue $465K (+49% year over year), operating margin -133.5%, net loss $617K, operating cash flow −$494K. The chart follows the revenue to costs, profit and cash.
| Q2 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $465K | +61% | +49% |
| Operating profit | −$622K | — | — |
| Net earnings | −$617K | — | — |
| Operating cash flow | −$494K | — | — |
What changed
Revenue was $465K in Q2 2025, up 49% year over year and up 61% from the previous quarter. Product Health Therapies was the largest line at 47% of revenue. Soy Protein Isolate Powder declined 68%.
Gross margin was 44.9%, down 16.9 points from a year earlier. Operating costs exceeded revenue by $622K, an operating margin of -133.5%. Operating expenses grew 28% against revenue growth of 49%. The fastest-growing cost line was Sales & marketing (+58%). The quarter ended with a net loss of $617K, narrower than the previous quarter's $699K loss.
Operating cash flow was −$494K. Non-cash charges added back $5K of depreciation and amortization. Working capital and other items added $118K. Capital expenditures of $0K exceeded it, leaving free cash flow of −$494K.
Questions
What was Agape ATP's revenue in the second quarter 2025?
Agape ATP (ATPC) reported revenue of $465K for the second quarter 2025 (Q2 2025), +49% from a year earlier and +61% from the quarter before.
Was Agape ATP profitable in the second quarter 2025?
Operating loss was $622K (-133.5% of revenue) and net loss $617K.
Source: Agape ATP 10-Q on SEC EDGAR.